Home » News » Update on new experimental Alzheimer’s drug Update on new experimental Alzheimer’s drug Published On: April 5, 2021Shared by brackett According to early clinical trial results, recently published in The New England Journal of Medicine, a new experimental intravenous drug donanemab could slow cognitive decline. Click HERE to read the full story. Article Categories: News, Newsletter